期刊论文详细信息
NEUROBIOLOGY OF AGING 卷:94
Gray matter changes related to microglial activation in Alzheimer's disease
Article
Nicastro, Nicolas1,2  Malpetti, Maura3  Mak, Elijah1  Williams, Guy B.4  Bevan-Jones, W. Richard3  Carter, Stephen F.1  Passamonti, Luca3,5  Fryer, Tim D.3,4  Hong, Young T.3,4  Aigbirhio, Franklin, I4  Rowe, James B.3,6  O'Brien, John T.1 
[1] Univ Cambridge, Dept Psychiat, Cambridge, England
[2] Geneva Univ Hosp, Dept Clin Neurosci, Geneva, Switzerland
[3] Univ Cambridge, Dept Clin Neurosci, Cambridge, England
[4] Cognit Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England
[5] CNR, Ist Bioimmagini & Fisiol Mol IBFM, Milan, Italy
[6] MRC, Cognit & Brain Sci Unit, Cambridge, England
关键词: Alzheimer's disease;    Neuroinflammation;    PET;    Grey matter;    Atrophy;    Cortical thickness;    MRI;   
DOI  :  10.1016/j.neurobiolaging.2020.06.010
来源: Elsevier
PDF
【 摘 要 】

Neuroinflammation is increasingly recognized as playing a key pathogenetic role in Alzheimer's disease (AD). We examined the relationship between in vivo neuroinflammation and gray matter (GM) changes. Twenty-eight subjects with clinically probable AD (n = 14) and amyloid-positive mild cognitive impairment (n = 14) (age 71.9 +/- 8.4 years, 46% female) and 24 healthy controls underwent structural 3T brain MRI. AD/mild cognitive impairment participants exhibited GM atrophy and cortical thinning in AD-related temporoparietal regions (false discovery rateecorrected p < 0.05). Patients also showed increased microglial activation in temporal cortices. Higher C-11-PK11195 binding in these regions was associated with reduced volume and cortical thickness in parietal, occipital, and cingulate areas (false discovery rate p < 0.05). Hippocampal GM atrophy and parahippocampal cortical thinning were related to worse cognition (p < 0.05), but these effects were not mediated by microglial activation. This study demonstrates an association between in vivo microglial activation and markers of GM damage in AD, positioning neuroinflammation as a potential target for immunotherapeutic strategies. (C) 2020 The Author(s). Published by Elsevier Inc.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_neurobiolaging_2020_06_010.pdf 3034KB PDF download
  文献评价指标  
  下载次数:6次 浏览次数:0次